Clinical trials
Phase 1/2 trials in Canada with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 6 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 3 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sunnybrook Health Sciences Centre | 7 |
| University Health Network, Toronto | 5 |
| University of British Columbia | 3 |
| AHS Cancer Control Alberta | 2 |
| BioSurface Engineering Technologies, Inc | 2 |
| Kartos Therapeutics, Inc. | 2 |
| McGill University | 2 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 2 |
| Ottawa Hospital Research Institute | 2 |
| Unity Health Toronto | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 6 |
| Lymphoma, Non-Hodgkin | 3 |
| Breast Neoplasms | 2 |
| COVID-19 | 2 |
| Hearing Loss | 2 |
| Multiple Myeloma | 2 |
| Recurrence | 2 |
| Urinary Tract Infections | 2 |
| Adenoviridae Infections | 1 |
| Agnosia | 1 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.